A rhodium-catalyzed
olefination of aliphatic aldehydes with arylboroxines
is described. The simple rhodium(I) complex [Rh(cod)OH]2 without any external ligands or additives is able to catalyze the
reaction in air and neutral conditions, allowing the construction
of aryl olefins in an efficient manner with a good functional group
tolerance. The mechanistic investigation illustrates that the binary
rhodium catalysis is the key for the transformation, which involves
a Rh(I)-catalyzed 1,2-addition and a Rh(III)-catalyzed elimination.
Transition-metal-catalyzed nucleophilic dearomatization of electron-deficient heteroarenes, such as pyridines, quinolines, isoquinolines and nitroindoles, has become a powerful method for the access of unsaturated heterocycles in recent decades. This short review summarizes nucleophilic dearomatization of electron-deficient heteroarenes with carbon- and heteroatom-based nucleophiles via transition-metal catalysis. A great number of functionalized heterocycles were obtained in this transformation. Importantly, many of these reactions were carried out in an enantioselective manner by means of asymmetric catalysis, providing a unique method for the construction of enantioenriched heterocycles.
1 Introduction
2 Transition-metal-catalyzed nucleophilic dearomatization of heteroarenes via alkynylation
3 Transition-metal-catalyzed nucleophilic dearomatization of heteroarenes via arylation
4 Transition-metal-catalyzed nucleophilic dearomatization of heteroarenes with other nucleophiles
5 Transition-metal-catalyzed nucleophilic dearomatization with nucleophiles formed in situ
6 Conclusion and outlook
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.